{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:53:28Z","timestamp":1760234008672,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FWF Vienna Austria","award":["HOROS doctoral Program, W1253-B24"],"award-info":[{"award-number":["HOROS doctoral Program, W1253-B24"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The rapid spread of the virus in Latin America and the association of the infection with microcephaly in newborns or Guillain\u2013Barr\u00e9 Syndrome in adults prompted the WHO to declare the Zika virus (ZIKV) epidemic to be an international public health emergency in 2016. As the virus was first discovered in monkeys and is spread not only by mosquitos but also from human to human, we investigated the stability to the human complement of ZIKV derived from mosquito (ZIKVInsect), monkey (ZIKVVero), or human cells (ZIKVA549 and ZIKVFibro), respectively. At a low serum concentration (10%), which refers to complement concentrations found on mucosal surfaces, the virus was relatively stable at 37 \u00b0C. At higher complement levels (up to 50% serum concentration), ZIKV titers differed significantly depending on the cell line used for the propagation of the virus. While the viral titer of ZIKVInsect decreased about two orders in magnitude, when incubated with human serum, the virus derived from human cells was more resistant to complement-mediated lysis (CML). By virus-capture assay and Western blots, the complement regulator protein CD55 was identified to be incorporated into the viral envelope. Blocking of CD55 by neutralizing Abs significantly increased the sensitivity to human complement. Taken together, these data indicate that the incorporation of CD55 from human cells contributes to the stability of ZIKV against complement-mediated virolysis.<\/jats:p>","DOI":"10.3390\/v13030510","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T23:47:41Z","timestamp":1616370461000},"page":"510","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Incorporation of CD55 into the Zika Viral Envelope Contributes to Its Stability against Human Complement"],"prefix":"10.3390","volume":"13","author":[{"given":"Zahra","family":"Malekshahi","sequence":"first","affiliation":[{"name":"Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bernklau","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Schiela","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Koske","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-5800","authenticated-orcid":false,"given":"Zoltan","family":"Banki","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1902-8674","authenticated-orcid":false,"given":"Karin","family":"Stiasny","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-1730","authenticated-orcid":false,"given":"Claire L.","family":"Harris","sequence":"additional","affiliation":[{"name":"Translational &amp; Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-442X","authenticated-orcid":false,"given":"Reinhard","family":"W\u00fcrzner","sequence":"additional","affiliation":[{"name":"Institute of Hygiene &amp; Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heribert","family":"Stoiber","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","article-title":"The emergence of Zika virus and its new clinical syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pntd.0002636","article-title":"Molecular evolution of Zika virus during its emergence in the 20(th) century","volume":"8","author":"Faye","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3201\/eid2410.172079","article-title":"Zika Virus Infection during Pregnancy and Effects on Early Childhood Development, French Polynesia, 2013\u20132016","volume":"24","author":"Subissi","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S2352-4642(18)30020-8","article-title":"Association and birth prevalence of microcephaly attributable to Zika virus infection among infants in Para\u00edba, Brazil, in 2015\u20132016: A case-control study","volume":"2","author":"Moore","year":"2018","journal-title":"Lancet Child. Adolesc. Health"},{"key":"ref_7","first-page":"e3","article-title":"Zika Virus Infection-After the Pandemic. Reply","volume":"382","author":"Musso","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41594-017-0010-8","article-title":"Structural biology of Zika virus and other flaviviruses","volume":"25","author":"Hasan","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_9","first-page":"1","article-title":"ZIKV viral proteins and their roles in virus-host interactions","volume":"14","author":"Guo","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2009.11.009","article-title":"Structure and functionality in flavivirus NS-proteins: Perspectives for drug design","volume":"87","author":"Bollati","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"I100","DOI":"10.1016\/j.vaccine.2008.11.061","article-title":"Complement and its role in protection and pathogenesis of flavivirus infections","volume":"26","author":"Avirutnan","year":"2008","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fmicb.2017.00213","article-title":"The Complement System in Flavivirus Infections","volume":"8","author":"Conde","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2018.02177","article-title":"Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex","volume":"9","author":"Schiela","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"69549","DOI":"10.3389\/fimmu.2020.569549","article-title":"Interference of the Zika Virus E-Protein With the Membrane Attack Complex of the Complement System","volume":"11","author":"Malekshahi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement System Part I-Molecular Mechanisms of Activation and Regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement System Part II: Role in Immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1385\/IR:33:2:103","article-title":"The role of the complement system in innate immunity","volume":"33","author":"Rus","year":"2005","journal-title":"Immunol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"20160221","DOI":"10.1098\/rstb.2016.0221","article-title":"The mystery behind membrane insertion: A review of the complement membrane attack complex","volume":"372","author":"Bubeck","year":"2017","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrmicro1824","article-title":"Complement evasion by human pathogens","volume":"6","author":"Lambris","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fimmu.2020.01450","article-title":"Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics","volume":"11","author":"Mellors","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molimm.2004.06.024","article-title":"Complement-opsonized HIV: The free rider on its way to infection","volume":"42","author":"Stoiber","year":"2005","journal-title":"Mol. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/femsre\/fuz012","article-title":"Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity","volume":"43","author":"Dittmer","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1073\/pnas.112220499","article-title":"Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement","volume":"99","author":"Rosengard","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.174.4.2143","article-title":"Electrostatic Modeling Predicts the Activities of Orthopoxvirus Complement Control Proteins","volume":"174","author":"Sfyroera","year":"2005","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1128\/JVI.77.6.3878-3881.2003","article-title":"Kaposi\u2019s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Open Reading Frame 4 Protein (Kaposica) Is a Functional Homolog of Complement Control Proteins","volume":"77","author":"Mullick","year":"2003","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ejaz, A., Steinmann, E., B\u00e1nki, Z., Khalid, A.S., Lengauer, S., Wilhelm, C., Zoller, H., Schloegl, A., and Steinmann, J. (2012). Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045770"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9570","DOI":"10.1128\/JVI.00912-16","article-title":"Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins","volume":"90","author":"Conde","year":"2016","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e00567-19","DOI":"10.1128\/JVI.00567-19","article-title":"Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum","volume":"93","author":"Pipperger","year":"2019","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-1759(02)00207-7","article-title":"Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: Pitfalls and solutions","volume":"268","author":"Harris","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1242\/jcs.062950","article-title":"Selective export of human GPI-anchored proteins from the endoplasmic reticulum","volume":"123","author":"Bonnon","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/hep.24686","article-title":"CD59 incorporation protects hepatitis C virus against complement-mediated destruction","volume":"55","author":"Amet","year":"2012","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1128\/JVI.00917-13","article-title":"Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles","volume":"87","author":"Mazumdar","year":"2013","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1128\/JVI.00713-09","article-title":"The Paramyxoviruses Simian Virus 5 and Mumps Virus Recruit Host Cell CD46 To Evade Complement-Mediated Neutralization","volume":"83","author":"Johnson","year":"2009","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1099\/0022-1317-78-8-1907","article-title":"Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction","volume":"78","author":"Saifuddin","year":"1997","journal-title":"J. Gen. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/viro.1994.1622","article-title":"Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection","volume":"205","author":"Montefiori","year":"1994","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/eji.1830250147","article-title":"Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement","volume":"25","author":"Marschang","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1440-1746.2001.02418.x","article-title":"Polymorphic expression of decay-accelerating factor in human colorectal cancer","volume":"16","author":"Nakagawa","year":"2001","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/3\/510\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:38:10Z","timestamp":1760161090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/3\/510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["v13030510"],"URL":"https:\/\/doi.org\/10.3390\/v13030510","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2021,3,19]]}}}